Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
457
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics
Private Equity | Healthcare

TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics

Hutchinson Technology, Inc., a subsidiary of TDK Corporation, has sold its medical business HTI Medical to Resonetics, a portfolio company of GTCR.

Learn more
Vascotube GmbH has been acquired by Cirtec Medical Systems, LLC
Healthcare | Private Equity

Vascotube GmbH has been acquired by Cirtec Medical Systems, LLC

Ordito GmbH, a private investment company, has sold Vascotube GmbH, a leading German manufacturer of high quality nitinol tubing, to 3i-backed Cirtec Medical Systems, LLC (Cirtec), a provider of design and contract manufacturing services for implantable and minimally invasive surgical devices. Financial details will remain confidential.

Learn more
Bluebird Care has been acquired by Interim Healthcare Inc.
Healthcare

Bluebird Care has been acquired by Interim Healthcare Inc.

US-based care-at-home franchisor Interim Healthcare Inc. has acquired Bluebird Care, based in the UK, a national provider of care in the home. Financial details have not been provided.

Learn more
“We’re excited to be joining the Calibre Scientific family, who will enable us to further accelerate our long-term strategic growth objectives. The Oaklins Cavendish team has achieved a fantastic result for our shareholders. Their wealth of sector expertise, professionalism and unwavering dedication throughout the process were instrumental in achieving a successful completion.”

Darren Likely

CEO, Agar Scientific Ltd.

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=US&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Upturn in cross-border M&A activity despite ongoing economic turmoil

SUMMER DEAL ACTIVITY: The ongoing economic turmoil is impacting M&A markets but the appetite for M&A persists with 37 transactions closed in July and August, capitalizing in particular on overseas interest with cross-border transactions making up 67% of the total.

Learn more

Talk to our local specialists

 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital

Meet our global industry specialists

 Robert  Boersma

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands
 Dino  Theodorou

Dino Theodorou

Director
Johannesburg, South Africa
Oaklins Grindrod
 Stuart  Goodman

Stuart Goodman

Director
London, United Kingdom
Oaklins Evelyn Partners
 Michael  Jewell

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish